Peptide-Mediated Disruption of NFκB/NRF Interaction Inhibits IL-8 Gene Activation by IL-1 or Helicobacter pylori1

Selective inhibition of proinflammatory chemokines such as IL-8 is an important approach to combat inflammatory and infection diseases. Previous studies suggested that interaction of transcription factors NFκB repressing factor (NRF) and NFκB play a crucial role in activation of IL-8 gene expression. In a search for a specific inhibitor of IL-8 expression, we applied tandem affinity purification to investigate interaction of NRF and NFκB p65 in cells. We identified a synthetic peptide corresponding to aa 223–238 of NRF interfering with binding of endogenous p65 to NRF. Furthermore, nucleofection experiments were established to introduce this inhibitory peptide into the nucleus of IL-1 stimulated human cervical and Helicobacter pylori infected gastric epithelial cells. Our data clearly show that the specific peptide disturbing NRF/NFκB interaction is able to significantly decrease endogenous IL-8 gene transcription in response to IL-1 or Helicobacter pylori infection. Thus, our study provides novel insights into NRF and NFκB interaction in vivo and may facilitate the design of new anti-IL-8 drugs based on novel strategies.

[1]  M. Baggiolini,et al.  Chemokines in inflammation and immunity. , 2000, Immunology today.

[2]  M. Manns,et al.  Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. , 1997, Gastroenterology.

[3]  S. Mohan,et al.  A platform of high-efficiency nonviral gene transfer in mouse osteoblast cells in vitro , 2006, Molecular biotechnology.

[4]  B. Séraphin,et al.  A generic protein purification method for protein complex characterization and proteome exploration , 1999, Nature Biotechnology.

[5]  Devanand Sarkar,et al.  Molecular mechanisms of aging-associated inflammation. , 2006, Cancer letters.

[6]  M. Upton,et al.  Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. , 1997, Gastroenterology.

[7]  C. Power,et al.  The chemokine system: novel broad-spectrum therapeutic targets. , 2001, Current opinion in pharmacology.

[8]  M. Entman,et al.  The inflammatory response in myocardial infarction. , 2002, Cardiovascular research.

[9]  Ivan Dikic,et al.  Ubiquitylation and cell signaling , 2005, The EMBO journal.

[10]  J. L. Rosa,et al.  Interaction and Functional Cooperation of NF-κB with Smads , 2000, The Journal of Biological Chemistry.

[11]  R. Frank.  The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications. , 2002, Journal of immunological methods.

[12]  G. Verbruggen.  Chondroprotective drugs in degenerative joint diseases. , 2006, Rheumatology.

[13]  R. Winzen,et al.  Stress-activated Protein Kinase/Jun N-terminal Kinase Is Required for Interleukin (IL)-1-induced IL-6 and IL-8 Gene Expression in the Human Epidermal Carcinoma Cell Line KB* , 1998, The Journal of Biological Chemistry.

[14]  M. Baccarani,et al.  Nucleofection Is an Efficient Nonviral Transfection Technique for Human Bone Marrow–Derived Mesenchymal Stem Cells , 2006, Stem cells.

[15]  B. Aggarwal,et al.  Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy , 2006 .

[16]  B E Dunn,et al.  Helicobacter pylori , 1997, Clinical microbiology reviews.

[17]  M. Manns,et al.  Effect of H. pylori on the Expression of TRAIL, FasL and their Receptor Subtypes in Human Gastric Epithelial Cells and their Role in Apoptosis , 2004, Helicobacter.

[18]  R. Peek,et al.  Identification of a signaling cascade for interleukin-8 production by Helicobacter pylori in human gastric epithelial cells. , 2002, Biochemical pharmacology.

[19]  D. Tompkins,et al.  CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. , 1994, Journal of clinical pathology.

[20]  K. Roebuck.  Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review). , 1999, International journal of molecular medicine.

[21]  C. Mackay,et al.  Chemokines: immunology's high impact factors , 2001, Nature Immunology.

[22]  J. Primrose,et al.  Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. , 1994, Journal of clinical pathology.

[23]  K. Yamamoto,et al.  The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. , 2005, Genes & development.

[24]  David Baltimore,et al.  One Nucleotide in a κB Site Can Determine Cofactor Specificity for NF-κB Dimers , 2004, Cell.

[25]  T. Maniatis,et al.  Identification of the rel family members required for virus induction of the human beta interferon gene , 1995, Molecular and cellular biology.

[26]  J. Crabtree,et al.  Mucosal interleukin-8 and Helicobacter pylori-associated gastroduodenal disease. , 1994, European journal of gastroenterology & hepatology.

[27]  A. Baldwin,et al.  Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B , 1993, Molecular and Cellular Biology.

[28]  H. Hauser,et al.  Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-κB-repressing factor (NRF) in basal repression of the hiNOS gene , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Klein,et al.  Helicobacter pylori infection of human gastric epithelial cells induces IL-8 and TNFα, but not TGFβ1 mRNA , 2000 .

[30]  T. Murayama,et al.  [Molecular mechanism of interleukin-8 gene expression]. , 1994, Rinsho byori. The Japanese journal of clinical pathology.

[31]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[32]  C. March,et al.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. , 1988, Science.

[33]  K. Resch,et al.  NF-κB-Repressing Factor Inhibits Elongation of Human Immunodeficiency Virus Type 1 Transcription by DRB Sensitivity-Inducing Factor , 2005, Molecular and Cellular Biology.

[34]  Richard S Larson,et al.  Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction. , 2005, Current protein & peptide science.

[35]  H. Hauser,et al.  The NF-κB Repressing Factor Is Involved in Basal Repression and Interleukin (IL)-1-induced Activation of IL-8 Transcription by Binding to a Conserved NF-κB-flanking Sequence Element* , 2001, The Journal of Biological Chemistry.

[36]  A. Shimizu,et al.  Properties of human interleukin-2 receptors expressed on non-lymphoid cells by cDNA transfection. , 1984, Molecular biology & medicine.

[37]  K. Umezawa,et al.  JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma. , 2005, Cancer research.

[38]  L. Jonk,et al.  TAK1 activation of the mouse JunB promoter is mediated through a CCAAT box and NF‐Y , 2001, FEBS letters.

[39]  H. Hauser,et al.  Innate Immune Responses in NF-κB-Repressing Factor-Deficient Mice , 2006, Molecular and Cellular Biology.

[40]  N. Arai,et al.  Effect of H2 Addition on Soot Formation in Fuel-Rich CH4/Air Turbulent Diffusion Flames , 2002 .

[41]  J. L. Rosa,et al.  Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter. , 2000, The Journal of biological chemistry.

[42]  H. Hauser,et al.  Constitutive silencing of IFN‐β promoter is mediated by NRF (NF‐κB‐repressing factor), a nuclear inhibitor of NF‐κB , 1999 .